Eli Casdin
Chief Investment Officer at Casdin Capital
New York, New York
Overview
Work Experience
Chief Investment Officer
2011 - Current
Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry.
Board Member
2021
Board Member
2020
The mission of New York Genome Center is to save lives by creating an unprecedented collaboration of technology, science, and medicine.
Raised $131,000,000.00 from Simons Foundation, The Carson Family Charitable Trust, Alfred P. Sloan Foundation and Alfred P. Sloan Foundation.
Member, Board of Visitors
2015
Board Member
2022
Board Member
2020
GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Raised $941,000,000.00 from Pfizer, SoftBank Capital, Deerfield, Perceptive Advisors, Counterpoint Global, Viking Global Investors, T. Rowe Price, Casdin Capital, BlackRock and Fidelity.
Board Member
2018
JJDC finds transformative ideas and helps them mature into real solutions for today’s patients.
Board Member
2018
Genomatica manufactures sustainable chemicals from renewable feedstocks.
Raised $340,252,740.00 from Lululemon.
Board Member
2020 - 2024
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Raised $956,517,993.00 from Casdin Capital, T. Rowe Price, Illumina, Farallon Capital Management, SoftBank Capital, Perceptive Advisors, Counterpoint Global, ARK Investment Management, Corvex and Janus Henderson Investors.
Board Member
2019 - 2022
Education
MBA
2002 - 2003
Bachelor of Science
2001 - 2003